|
|
||||||||
1 Unité Mixte de Recherches sur la Production du Lait, Institut National de la Recherche Agronomique, 35590 Saint Gilles, France
2 IRTA, Unidad de Ruminates, Edificio V, 08193 Bellaterra, Spain
3 Division of Animal Nutrition and Physiology, Institute of Animals Genetics, Nutrition and Housing, University of Berne, CH-3312 Berne, Switzerland
Corresponding author: S. Lemosquet; e-mail: lemosque{at}st-gilles.rennes.inra.fr.
| ABSTRACT |
|---|
|
|
|---|
Key Words: dairy cow propionic acid glucose glucose metabolism
Abbreviation key: BCAA = branched-chain AA, C3 = propionic acid, EAA = essential AA, GH = growth hormone, NEAA = nonessential AA, Ra = glucose appearance rate, RMSE = root mean square error, TAA = total AA
| INTRODUCTION |
|---|
|
|
|---|
The effects of post-ruminal glucose or starch infusions of several-day duration on Ra have only been measured in a few studies in lactating dairy cows (Clark et al., 1977; Knowlton et al., 1998; Rigout et al., 2002b). A significant increase in Ra was observed in response to graded amounts of glucose infused into the duodenum when cows were fed at 110% of protein requirement (Rigout et al., 2002b) or when glucose was abomasally infused at one dose in addition to casein infusion; glucose alone had no effect (Clark et al., 1977). These results suggest that protein supply should not be limiting to increased Ra. The abomasal infusion of starch also tended to increase Ra in comparison with ruminal infusion (Knowlton et al., 1998). To our knowledge, the effect of ruminal infusion of C3 on Ra was never measured in lactating dairy cows. In other ruminants, the effect of C3 infusions on Ra differed among experiments. A significant increase in Ra was reported in non-lactating ruminants (Baird et al., 1980; Veenhuizen et al., 1988; Peiris et al., 1998), but no increase was observed in lactating ruminants (Baird et al., 1980; Casse et al., 1994; Danfaer et al., 1995). Results may also depend on the site of infusion intravenously (Baird et al., 1980; Casse et al., 1994; Danfaer et al., 1995) or ruminally (Judson and Leng, 1973; Veenhuizen et al., 1988; Peiris et al., 1998), which may change the nature and the amounts of precursors available for gluconeogenesis. When C3 is administered into the rumen, a part of C3 is metabolized into the rumen wall (Seal and Parker, 1994) and in comparison with intravenous infusion, only a part of the rumen C3 appears in the portal vein. However, portal appearance of lactate and alanine may increase (Seal and Parker, 1994). Lastly, results may depend on the duration of infusions, amounts infused, and on total energy intake (Casse et al., 1994). In lactating cows, the effect of ruminal C3 and duodenal glucose were never compared, but infusions of starch into the rumen had no effect on Ra or only slightly increased hepatic glucose production. Abomasal infusion of starch tended to increase Ra or increased net glucose absorption (Reynolds et al., 1997; Knowlton et al., 1998). However, if ruminal starch infusion likely increased production of ruminal propionate (Knowlton et al., 1998), then ruminal starch fermentation also produced VFA other than C3 and part of fermented C is used in the synthesis of microbial cells. The relative efficiency of glucose and C3 in increasing Ra was only compared on 2 occasions: during short-term intravenous infusion in lactating dairy cows (Baird et al., 1980) through low levels of supplementation in the digestive tract of steers (Peiris et al., 1998). However, in those treatments glucose and C3 were given as a supplement to the diet, and infusions were neither isomolar nor isoenergetic, which might confuse the positive effect of energy absorbed on Ra (Wieghart et al., 1986) and the specific effect of the nature of the nutrients.
Increasing amounts of C3 or glucose increased milk protein yield in parallel with milk yield (Rigout et al., 2003), suggesting that milk protein yield could be limited by glucose supply in cows receiving grass silage (Huhtanen et al., 2002). Several hypotheses on AA metabolism are proposed to explain this increased protein yield. First, increasing glucogenic materials (i.e., ruminal C3 or post-ruminal glucose) may reduce the utilization of some AA for gluconeogenesis and increase the supply and uptake of glucogenic AA to the mammary gland. This hypothesis is not likely able to explain the increased protein yield obtained with duodenal glucose infusions because these treatments did not increase the uptake of glucogenic AA by the mammary gland (Rigout et al., 2001) but increased the uptake of essential amino acids (EAA) (Rigout et al., 2001). However, a sparing effect of C3 on glucogenic AA cannot be excluded.
The objective of the current study was to compare, on an isoenergetic basis, the effects of C3 infused into the rumen and glucose infused into the duodenum on glucose metabolism in lactating dairy cows. Measurements of milk yield, milk composition, and energy and protein supplied have been published (Rigout et al., 2003). The present paper focuses on the variations in Ra, plasma metabolites, and hormones involved in the regulation of gluconeogenesis and in the partitioning of glucose and AA for the different metabolic functions.
| MATERIALS AND METHODS |
|---|
|
|
|---|
The experiment was conducted according to a 5 x 5 Latin square design over 14-d periods (9 d of transition and adaptation and 5 d of measurements).
Cows, Feed Distribution, and Milking
Five Holstein cows (613 ± 62 kg of BW; 53 ± 12 DIM; 32 ± 4 kg/d of milk yield) fitted with a rumen cannula and a T-shaped duodenal cannula were used. Grass silage was fed 3 times/d (25% at 0700 h, 25% at 1300 h, and 50% at 1900 h), and concentrate was fed 8 times/d in equal portions (every 3 h beginning at 0700 h). Access to feed was limited to 1 h every 3 h beginning at 0700 h. With such a pattern of feed distribution, plasma glucose concentration remained stable, as did plasma concentrations of most blood metabolites (AA, acetate, BHBA, NEFA, urea) and hematocrit (Rulquin, 1981). Cows were milked twice daily at 0630 and 1800 h.
The surgical preparation was reviewed and approved by the animal care committee of the French Ministry of Agriculture. Cows were fitted with two provisional silicone catheters (length, 21 cm; i.d., 1.02 mm; o.d., 2.16 mm; Silclear Tubing, Degania, Israel) inserted into the 2 jugular veins for tracer infusions and blood sampling during the measurement of Ra. Catheter maintenance was as described by Rigout et al. (2002b).
Measurements and Sampling
The effect of treatments on Ra was measured on d 10 or 11 between 1315 and 1530 h. Two 98.0% pure solutions of [6,6-2H2]glucose (Cambridge Isotope Laboratories, Andover, MA) were prepared with sterile saline for the priming dose injection and infusion and were sterilized by filtration through a 0.22-µm sterile disk filter (Millipore, Saint-Quentin en Yvelines, France). The first solution (77.1 ± 0.8 g/L) was used for the priming dose injected through one jugular vein (35 mL; 2.7 g). The second solution (54.9 ± 0.8 g/L) was then continuously infused at a constant rate of 1.3 mL/min for 120 min with a syringe pump (Harvard apparatus, Les Ulis, France). To control for blood glucose coefficients of variation that were <5%, 1 mL of blood was taken every 10 min (from 20 min before the beginning to 80 min) from the other jugular vein catheter to perform a rapid measurement of blood glucose concentration using a glucometer (LifeScan One touch; Johnson & Johnson Company, Milpitas, CA). In addition, blood samples were collected with syringes (S-Monovette, 7.5 mL; Sarstedt, Nümbrecht, Germany) containing heparin (12 to 30 IU/mL) at 15 and 10 min before injection of [6,6-2H2]glucose solution to measure the natural abundance and during the plateau period, at 80, 90, 100, and 110 min after injection. Blood was centrifuged at 2500 x g for 10 min at 4°C. Plasma samples for glucose assays were stored at 20°C. Plasma samples taken to measure [6,62H2]glucose enrichments were deproteinized with an equal volume of 1.2 M perchloric acid and filtrated before being stored at 20°C.
Jugular blood was sampled on d 13 of each period at 0.5, 2.5, 4.5, 6.5, 8.5, and 10.5 h after morning milking. Syringes containing heparin (S-Monovette, 7.5 ml; Sarstedt) were used for AA, lactate, and urea determinations. Samples for insulin, growth hormone (GH), and IGF-I determinations were collected with syringes containing 1.2 to 2 mg/mL of K2-EDTA (S-Monovette, 7.5 ml; Sarstedt). Syringes containing K2-EDTA (2.6 mL) and 260 µL (2600 KIU) of the protease inhibitor aprotinine (Antagosan; Hoechst Marion Roussel Gmbh, Marbourg, Germany) were used to collect blood for determination of glucagon concentrations. Blood samples were kept on ice and centrifuged at 2500 x g for 10 min at 4°C before storage at 20°C.
Samples taken for lactate and AA analyses were deproteinized with 50% vol/vol of 0.6 M perchloric acid and filtrated with 50% (vol/vol) sulfosalicylic acid.
On d 13 of each period, 100 mL of milk were taken from each cow at the morning milking. Milk samples were stored at 20°C for chemical analyses in the laboratory. Milk was analyzed for glucose concentration in milk according to Rigout et al. (2002b).
Chemical Analyses
Samples for lactate, urea, and AA were pooled per cow per period before analyses. Glucose, lactate, and urea were measured on a multiparameter analyzer (KONE Instruments Corporation, Espoo, Finland) using a KONE kit for glucose, a Bio-Mérieux kit (Bio-Mérieux S.A., Marcy-lEtoile, France) for L-lactate, and a Wako kit (Oxoid S.A., Dardilly, France) for NEFA determinations. Plasma-free AA concentrations were determined according to Hurtaud et al. (2000). Insulin, glucagon, GH, and IGF-I were analyzed by radioimmunoassay as described by Rigout et al. (2002b).
Preparation of samples before GLC/mass spectrometry analysis to determine [6,6-2H2]glucose enrichments was described by Rigout et al. (2002b). Derivatization was made with butaneboronic acid followed by addition of acetic anhydride. Each molar ratio (the ratio of [6,6-2H2]glucose to glucose; i.e., the ratio of m/z = 299 to m/z = 297) was determined in triplicate by GLC/mass spectrometry in electron impact ionization mode (GC 8060 chromatograph coupled to a VG Platform II; Fisons Instruments, Altrincham, England). The glucose enrichment expressed in molecular percentage excess was then calculated (Rigout et al., 2002b). A control plasma at 3.73 mol% excess was introduced in each batch of analysis; the coefficient of variation between batches was 1.63%.
Calculations and Statistical Analyses
Estimation of Ra (g/min), equal to hepatic plus renal production of glucose plus intestinal absorption of glucose, was determined by the steady-state equation:
![]() |
where F is the [6,6-2H2]glucose infusion rate (mL/min), IEinf is the isotopic enrichment of the infusate (i.e., 98 mol% excess), and IEp (also in mol% excess) is the plasma [6,6-2H2]glucose enrichment.
Mean values of each cow per period were used in statistical analyses. Each parameter was analyzed using the general linear model procedure of SAS (1990) according to the following statistical model: Yijk = µ + Ci + Pj + Tk + eijk where C, P, and T are cow, period, and treatment effects, respectively. Results were expressed as least squares means with standard errors of means because of missing values over period 4 for one cow that had mastitis. The VFA treatment was considered the control. Differences among treatments with least squares means were compared using 4 orthogonal polynomial contrasts between control (VFA), glucose dose 1 and 2 (G1 and G2), and C3 dose 1 and dose 2 (C31 and C32). Contrast A was used to test the effect of glucogenic materials such as duodenal glucose or ruminal C3 (control vs. other: 4VFA, 1G1, 1G2, 1C31, and 1C32). Contrast B was used to test duodenal glucose vs. ruminal propionic acid (1G1, 1G2, 1C31, and 1C32). Contrast C was used to test the effect of level of glucogenic materials (1G1, 1G2, 1C31, and 1C32). Contrast D was used to test the interaction between duodenal glucose and ruminal propionic (1G1, 1G2, 1C31, and 1C32). The significance threshold was set at P
0.05, and the tendency threshold was set at P
0.10.
| RESULTS |
|---|
|
|
|---|
|
Plasma lactate concentration remained unchanged with both glucogenic materials compared with the control. Plasma lactate concentration tended to be lower in response to duodenal glucose treatments compared with ruminal C3 treatments, and the interaction tended to be significant (Contrast D) because it decreased with the level of duodenal glucose and increased between the first and the second doses of ruminal C3.
Among EAA, both treatments significantly decreased the plasma concentrations of the three branched-chain AA (BCAA) and Thr compared with the control treatment (Table 2
; Contrast A). However, glucose treatments tended to significantly decrease BCAA compared with C3 treatments (Contrast B). The interaction tended to be significant (Contrast D) because BCAA decreased when the level of duodenal glucose increased, which was not the case with ruminal C3 infusions. Both glucogenic materials significantly decreased (Contrast A) the ratio of EAA to non essential AA (NEAA), but the decrease was significantly more important with glucose treatments compared with C3 treatments (Contrast B). Among NEAA, the sum of glucogenic AA concentrations increased in response to both glucose and C3 treatments (Contrast A), but the increase was significantly higher with glucose treatments compared with C3 treatments (Contrast B). Among glucogenic AA, considered to be highly oxidized, the sum of Asp + Asn and Ser, were significantly increased in response to both glucose and C3 treatments compared with the control treatment (Contrast A). The sum of Glu + Gln and Gly also increased with both treatments. However, the increases in some glucogenic AA (Ser and Gly) were significantly higher or tended to be higher (Glu + Gln) with glucose treatments than with C3 treatments. Urea remained unchanged during treatments. The interaction between glucose and C3 treatments was significant for Thr, Asp + Asn, Ala, and Orn or tended to be significant for Lys, His, Val, EAA, NEAA, total AA (TAA), BCAA, and glucogenic AA because the concentrations decreased with increasing levels of duodenal glucose and increased with increasing levels of ruminal C3.
|
| DISCUSSION |
|---|
|
|
|---|
Duodenal Glucose Increase in Ra May Follow a Sigmoidal Curve
Increasing amounts of glucose infused into the duodenum increased Ra (Figure 1
) in the present experiment as in the previous experiment (Rigout et al., 2002b). The sum of intestinal glucose provided by the diets and the infusions were calculated for each glucose treatment in both experiments (Rigout et al., 2003). Using these experiments, Ra seemed to increase following a sigmoidal curve in response to increasing total amounts of duodenal glucose (Figure 1a
). This result differed from steers whose net portal glucose absorption increased linearly in response to increasing amounts of glucose infused between 0 and 8 mol/d (Kreikemeier et al., 1991). If our data were fitted to a linear regression, the increase in Ra with total duodenal glucose would correspond to a slope of +0.46 mol/mol of glucose. This value was lower than the slope of net portal glucose absorption (+0.62 mol/mol) obtained with similar amounts (44 to 55.5 mmol/kg0.75 per d) infused into steers (Kreikemeier et al., 1991). This difference may be explained by a reduction of endogenous glucose production. In our two experiments, better results were obtained when mean data were fitted according to the sigmoidal curve (R2 = 0.98; SE = 0.46 mol/d) than to a linear regression (R2 = 0.90; SE = 0.74 mol/d). The robustness of the beginning of the sigmoidal equation is a weak point because of the high SEM obtained in the present experiment. However, the high SEM was not due to glucose treatment, and the SEM was lower in the other experiment (+0.43 mol/d). In addition, to analyze the beginning of curve, the highest value (15.6 mol/d of total duodenal glucose) was excluded, and only 2.5 mol/d to 11 mol/d of total glucose were considered (Figure 1b
). In this case, the data were still better fitted using a quadratic regression (R2 = 0.93; SE = 0.56 mol/d) than a linear regression (R2 = 0.84; SE = 0.74 mol/d).
|
In Figure 1
, at 5.6 to 10 mol/d of duodenal glucose (from 3 to 8 mol/d of glucose infused), the small intestine did not further increase the amount of glucose directly utilized when absorbed. In addition, endogenous glucose release was not reduced because the slope of Ra increase was about 0.9. A similarly substantial recovery of infused glucose in the portal vein was reported in steers infused with 2.66 mol/d of glucose (Kreikemeier et al., 1991). In sheep and steers, the recovery of infused glucose varied on average between 29 and 84% (Piccioli Capelli et al., 1997).
At >12.2 mol/d of duodenal glucose in Fig. 1
, Ra tended to reach the asymptotic line, suggesting that hepatic gluconeogenesis was decreased as observed in lactating cows receiving intravenous infusion of glucose (Baird et al., 1980). Below 16.6 mol/d, maximal intestinal capacity to absorb glucose was probably not reached in lactating dairy cows according to Huntington (1997).
At the High Dose, Duodenal Glucose Increased Ra, but the Effective Isoenergetic Supply of C3 on Ra Remained Unclear
Because of the high RMSE obtained for Ra in the present experiment, only the high dose of glucose infused into the duodenum increased (16.7 mol/d) more Ra than all the other treatments (13.0 to 13.9 mol/d), leading to a significant interaction between glucose and C3. The absence of any clear effect of the high dose of C3 infused into the rumen on Ra may be surprising. The absence of a significant increase in hepatic glucose net fluxes has already been observed in lactating cows receiving C3 infusions in the mesenteric vein (Lomax et al., 1979; Baird et al., 1980; Casse et al., 1994) and in lambs receiving C3 infusions into the rumen at doses similar to those in the present experiment (Majdoub et al., 2003). However, in the present experiment, if the value from Cow 5 receiving the high dose of C3 was removed from the data set, Ra would increase with C3 infused at the high dose (+14.8 mol/d), and the Ra would significantly increase in response to both glucogenic materials compared with the control treatment (Contrast A; P < 0.05) and in response to the level of infusions (Contrast C; P < 0.05).
Rate of appearance response to C3 administered in the rumen (infused or given as salt) was only measured in non-lactating ruminants in few experiments. Figure 2
shows the increase in Ra caused by C3 given when both C3 and Ra are expressed in mmol/kg0.75 per day of Carbon (3 x C3 and 6 x Ra, respectively). The increase observed with the C3 infusions in the present experiment (122 and 244 mmol of Carbon/kg0.75 per day of C3) was in the range of variation of those observed when C3 was given into the rumen (Figure 2
) at similar doses (94.4 to 367.4 mmol of C/kg0.75 per d) in sheep or steers (Judson and Leng, 1973; Veenhuizen et al., 1988). Data from Peiris et al. (1998) were inconsistent because the slope should not be >1. With the first dose of C3 infused or if the data from Cow 5 were suppressed at the high dose of C3, the slope of increase obtained in the present experiment would be very close to those (0.42 when expressed as carbon ratio) obtained by Veenhuizen et al. (1988). It should be noted, however, that, in the present experiment, the increase in Ra with ruminal C3 should have been >2.7 mol/d to be significant because of the high value of SEM, which involved a conversion efficiency for ruminal C3 to glucose >0.42 (when expressed in carbon ratio). The significant increases in Ra with C3 infusions in the experiment of Veenhuizen et al. (1988) might be linked to the lower SEM obtained and to the increased energy supply by C3 given because Ra increased with energy supply (Wieghart et al., 1986).
|
Factors Involved in the Effects of C3 and Glucose on Ra
An extensive C3 metabolism into the rumen wall might have explained the relatively low coefficient of conversion found in the present experiment. However, mean portal recovery rates of C3 infused were high and varied between 75 and 100% in steers (Seal and Parker, 1994) and in lambs (Majdoub et al., 2003) receiving similar infusion rates of C3 (122 mmol of C/kg0.75 per d to 219 mmol of C/kg0.75 per d) in comparison with the present experiment. In that regard, the only hypothesis to explain the low coefficient of conversion of infused C3 to Ra is that endogenous glucose release in blood and mainly liver net flux of glucose follows a curvilinear pattern in response to increasing infusions of C3. In the liver of lactating cows (Baird et al., 1980), the ratio of glucose release to C3 uptake decreased with C3 mesenteric infusions.
Propionic acid is a potent inhibitor of the other glucogenic pathways (Demigné et al., 1991), which might have decreased gluconeogenesis from substrates other than C3. However, in the present experiment, with the concentrations of AA, lactate, and insulin observed in peripheral blood, there is no evidence of a greater reduction of net hepatic glucose flux with ruminal C3 than with duodenal glucose. Both glucose infused into the duodenum and C3 into the rumen probably reduced gluconeogenesis from AA because plasma concentrations of glucogenic AA significantly increased with both glucogenic materials. The tendency for a higher plasma lactate concentration with the high dose of ruminal C3 relative to the high dose of glucose might indicate a higher conversion of propionate to lactate in the rumen, which might favor hepatic gluconeogenesis from lactate at the high C3 dose. It might also indicate reduced lactate utilization for gluconeogenesis. However, in lambs receiving ruminal C3 infusion at a similar dose, hepatic net flux of glucose remained unchanged despite an increase of portal availability of lactate and an unchanged fractional extraction by the liver (Majdoub et al., 2003). In addition, in lactating dairy cows, a substantial portion of the lactate assimilated by the liver is presumably not used for gluconeogenesis (Baird et al., 1983). Lastly, plasma insulin significantly increased in peripheral blood with the high dose of glucose infused into the duodenum compared with C3 infused into the rumen. The slightly increased insulin in peripheral blood with duodenal glucose is in agreement with previous studies (Lemosquet et al., 1997; Hurtaud et al., 2000; Rigout et al., 2002b). In addition, the absence of a significant increase in peripheral plasma insulin and hepatic glucose net fluxes has already been observed in lactating cows receiving C3 infusions in the mesenteric vein (Lomax et al., 1979; Baird et al., 1980; Casse et al., 1994) and in lambs receiving ruminal C3 infusions (Majdoub et al., 2003).
Glucose Utilization in the Mammary Gland
An increased Ra leading to increased glucose utilization by the mammary gland was the first hypothesis to explain the increased lactose production and milk yield generally observed with isoenergetic infusions of both glucose and C3 treatments (Rigout et al., 2002b, 2003). In this regard, when duodenal glucose was infused at the high dose, Ra (+16.7 mol/d) and milk yield (+26.8 kg/d) were higher than with the other treatments. Because of the higher Ra obtained at this dose, the interaction between glucose and C3 was significant. However, in the present experiment, milk yield only tended to increase (P = 0.09) with both glucogenic materials (Rigout et al., 2003). In that regard, it is difficult to analyze a small increase in milk response (tendency) in relation to the Ra measurement because of the high SEM obtained for Ra (+0.84 mol/d). In addition, the objective of this experiment was to avoid a confounding effect between the level of energy supply and changes in the nature of materials supplied to cows through isoenergetic treatments (diets plus infusions). Unfortunately, feed intake was depressed with the VFA infusion for the control treatment (Rigout et al., 2003), which might explain the tendency toward a lower milk yield for cows under the control treatment than for those treated with glucogenic materials because of the lower nutrient supplies to the mammary gland. For all these reasons, the present experiment did not indicate whether the increase in Ra is the key mechanism explaining the increased milk yield. However, the increase of mammary gland net balance of glucose accounted for 60% of the increase of Ra in a previous experiment of increasing infusions of duodenal glucose from 0 to 2.64/d Mcal of NEL (Rigout et al., 2002b) when treatments were isoenergetics. In addition, the bibliographical study showed that isoenergetic infusions of both post-ruminal glucose and ruminal C3 leads to a curvilinear increase in milk yield (Hurtaud et al., 2000; Rigout et al., 2003).
In the present experiment, with the high dose of glucose infused into the duodenum, Ra was not a further limiting factor to the increased lactose production and milk yield because the ratio of lactose production to Ra significantly decreased (0.45) compared with the other treatments (0.54), leading to a significant interaction between duodenal glucose and ruminal C3 treatments. In the previous experiment with duodenal glucose infusions (Rigout et al., 2002b), when a higher dose of glucose was infused (6.6 Mcal/d of NEL) than in the present experiment (3.45 Mcal/d of NEL), a change in the partition of glucose utilization between mammary and other tissues was observed because Ra continued to increase but mammary gland net uptake of glucose decreased. In the present experiment, the decrease in the ratio of lactose production to Ra may reflect a change in the partition of glucose utilization between mammary and other tissue. However, glucose concentration in milk was not decreased with glucose treatment at the high dose compared with C3 treatment. In the experiment of Rigout et al. (2002b), glucose concentration in milk followed mammary gland net balance of glucose. In addition, lactose production and milk yield did not decrease. This decrease in the ratio of lactose production to Ra may also partially result from a change in the partition of glucose utilization in the mammary gland between lactose synthesis and other utilization. Some mammary glucose might not have only been used for lactose, but might have also been used to generate energy for greater synthesis of NADPH through the pentose phosphate pathway (Rigout et al., 2002a, 2003) because the glucose treatments significantly increased mammary de novo synthesis of medium-chain fatty acids (Rigout et al., 2002a), which was not the case for C3 treatment (Rigout et al., 2003).
In the present experiment, the increased plasma IGF-I concentrations observed with both glucogenic materials may also be related to the parallel increases in milk yield and protein yield. The increase in plasma IGF-I concentration was possibly linked to increased blood flow (Bequette et al., 2001; Rigout et al., 2002b). In a previous experiment on duodenal glucose infusions (Rigout et al., 2001, 2002b), the increase in blood flow with a parallel increase in Ra allowed increased mammary gland net uptake of glucose when duodenal glucose infusions ranged from 0 to 2.64 Mcal/d of NEL. In addition, it was the only factor explaining the increased EAA uptake by the mammary gland and the increased milk protein yield because EAA concentrations and EAA arterio-venous differences remained unchanged (Rigout et al., 2001). In the present experiment, rumen C3 treatment might have had a similar effect on blood flow in comparison with duodenal glucose because both increased IGF-I concentrations.
| CONCLUSIONS |
|---|
|
|
|---|
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
Received for publication December 3, 2002. Accepted for publication November 8, 2003.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. Lemosquet, E. Delamaire, H. Lapierre, J. W. Blum, and J. L. Peyraud Effects of glucose, propionic acid, and nonessential amino acids on glucose metabolism and milk yield in Holstein dairy cows J Dairy Sci, July 1, 2009; 92(7): 3244 - 3257. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nikkhah, C. J. Furedi, A. D. Kennedy, G. H. Crow, and J. C. Plaizier Effects of Feed Delivery Time on Feed Intake, Milk Production, and Blood Metabolites of Dairy Cows J Dairy Sci, November 1, 2008; 91(11): 4249 - 4260. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Hammon, C. C. Metges, P. Junghans, F. Becker, O. Bellmann, F. Schneider, G. Nurnberg, P. Dubreuil, and H. Lapierre Metabolic Changes and Net Portal Flux in Dairy Cows Fed a Ration Containing Rumen-Protected Fat as Compared to a Control Diet J Dairy Sci, January 1, 2008; 91(1): 208 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. J. Cabrita, R. J. B. Bessa, S. P. Alves, R. J. Dewhurst, and A. J. M. Fonseca Effects of Dietary Protein and Starch on Intake, Milk Production, and Milk Fatty Acid Profiles of Dairy Cows Fed Corn Silage-Based Diets J Dairy Sci, March 1, 2007; 90(3): 1429 - 1439. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |